Methylphenidate analogs and methods of use thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/12 (2006.01) A61K 31/4458 (2006.01) A61P 25/28 (2006.01) C07D 211/14 (2006.01)

Patent

CA 2585014

Provided are analogs of methylphenidate (~MPH~) that are useful for the treatment of drug addiction, attention deficit disorder, attention deficit hyperactivity disorder, and depression. The MPH analogs are extend duration compounds that bind to the dopamine transporter and the reuptake of dopamine in the afflicted individual~s brain. Becauses of the extend duration of the MPH analogs, administration of the compounds is only required on a once or twice daily schedule.

L'invention concerne des analogues de méthylphénidate ( MPH ) utilisés dans le traitement de la toxicomanie, des troubles du déficit d'attention, de l'hyperactivité avec déficit d'attention et de la dépression. Lesdits analogues de MPH sont des composés à durée d'action prolongée qui se lient aux transporteurs de la dopamine et qui inhibent la réabsorption de la dopamine dans le cerveau des individus atteints. La durée d'action prolongée desdits analogues de MPH permet de n'administrer lesdits composés qu'une ou deux fois par jour.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methylphenidate analogs and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methylphenidate analogs and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylphenidate analogs and methods of use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1978569

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.